Erlonat Erlotinib

Product Details:

We are a supplier of Erlocip which is classified into the category of tyrosine kinase inhibitors that are used as anti-cancer drugs. Erlocip contains erlotinib which is widely used for the treatment of non-small cell lung carcinoma,a type of lung cancer which is insensitive to chemotherapy. This medicine is combined with for treating pancreatic cancer that has spread out to other body parts.

 

Specifications

• Content: Erlotinib
• Form: Tablet
• Packing: Pack Of 30 Tabs
• Strength: 150 mg
• Available as: 150 mg tablets
• manufactured By: Cipla

NOTE : Erlocip is a prescription drug and should be used under proper medical guidance and advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug.

Product Details:

We are engaged in offering one of the best medicines for the treatment of non-small cell lungs cancer useful for pancreatic cancer treatment. Erlonat helps in blocking the abnormal protein to show down the growth of cancer cells. These drugs also have some side effects like breathing, eye pain and irritation, vomiting, weakness, increased coughing and fever and chest pain etc.
our range of products are available with 100mg, 150 mg tablets as per treading price of market.

Product Details:

Specificiations:

Brand Name: Erlonat
Contains: Erlotinib
Strength: Erlonat 25 Mg , 100Mg & 150Mg Packing: Pack Of 30 Tablets

Note: Erlonat is a prescription drug and should be used under proper medical guidance and advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug.

Product Details:

Erlocip belongs to a class of medications called kinase inhibitors.

INDICATION
Erlocip is used for the treatment of non-small cell lung cancer. Erlocip is used for the treatment of pancreatic cancer that has spread to nearby tissues or to other parts of the body.

Mechanism of action
Erlocip works by blocking the action of an abnormal protein that slows the growth of cancer cells. This helps slow or stop the spread of cancer cells.

Supplied as
Erlocip is available as 150mg tablets.

Overdose
Symptoms of overdose associated with Erlocip may include diarrhea and rash.

Precautions & warnings

• Erlocip should not be taken without consulting your doctor if you have liver disease or lung or breathing problems (other than lung cancer).
• Do not take , or products containing unless it is permitted by the doctor.
• Take Erlocip several hours before or several hours after if you are taking antacids.
• Do not take Erlocip if you are allergic to it or to any ingredient in Erlocip.
• Do not take Erlocip without consulting your doctor if you are pregnant. Discuss with your doctor the appropriate use of birth control during treatment with Erlocip. It is not known whether Erlocip passes into breast milk. Do not take Erlocip without first talking to your doctor if you are breast feeding a baby.

Product Details:

erlotinib

• brand name: erlonat
• contains: erlotinib
• strength: erlonat 25 mg , erlonat 100mg & erlonat 150mg tablets
• packing: pack of 30 tablets

• brand name: erlonat
• contains: erlotinib
• strength: erlonat 25 mg , erlonat 100mg & erlonat 150mg tablets
• packing: pack of 30 tablets

 

note: erlonat is a prescription drug and should be used under proper medical guidance and advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug.

 

Product Details:

The Erlonat we offer are formulated by leading organizations using premium quality ingredients. These are useful for the treatment of non-small cell lung cancer. These belong to a class of medications called kinase inhibitors. Our range is used in combination with for the treatment of cancer.

 

Other Information

• Pay Mode Terms: L/C (Letter of Credit), D/A (Documents against Acceptance), D/P (Documents against Payment), T/T (Bank Transfer), Western Union, Other

Product Details:

Erlonat 150mg
erlonat 100mg
erlotinib
mfg. Natco, roche, glenmark, cipla

Product Details:

Erlonat
Erlonat belongs to a class of medications called Kinase inhibitors. It is used for the treatment of non-small cell lung cancer and in combination with , is used for the treatment of pancreatic cancer which spreads to adjacent tissues of the body. The action mechanism of the medicine is as follows:
Functions by blocking the action of an abnormal protein to slow down the growth of cancer cells

Supplied as:
Available in 25 mg, 100 mg & 150 mg tablets

Dosage:
Usually 150 mg tablet is administered, at least an hour before or two hours after the ingestion of food, for curing pancreatic non-small cell lung cancer. Erlonat is usually given as 100 mg tablets, at least an hour before or two hours after the intake of food, for curing of pancreatic cancer, in combination with .

Overdose
Symptoms of overdose may include diarrhea and rash

Precautions and warnings

• The medicine should not be taken without consulting the doctor if the patient has liver disease, lung or breathing problems (other than lung cancer).
• Do not take aspirin, or products containing aspirin, unless prescribed by the doctor Patient must take Erlonat at substantial time gap, if antacids are also being taken If the patient is allergic to the medicine or any of its constituents, then intake is not suggestible
• Erlonat consumption should avoided if the patient is pregnant or breast feeding the child. Doctor consultation suggested for use of birth control during treatment with Erlonat. It is not yet established whether Erlonat passes into breast milk or not.